Frequencies for first 10,000 rows of drug2cl1 variable in nhamcsed2003 dataset : drug class #1 for medication #2 | Freq. Percent Cum. ----------------------------------------+----------------------------------- anesthetics, local (injectable) | 60 0.60 0.60 anesthetics, general | 10 0.10 0.70 adjuncts to anesthesia/analeptics | 56 0.56 1.26 anesthetics, topical | 1 0.01 1.27 antidotes, specific | 4 0.04 1.31 antidotes, general | 1 0.01 1.32 antimicrobial agents, unspecified | 6 0.06 1.38 penicillins | 159 1.59 2.97 cephalosporins | 168 1.68 4.65 erythromycins/lincosamides/macrolides | 126 1.26 5.91 tetracyclines | 15 0.15 6.06 aminoglycosides | 5 0.05 6.11 sulfonamides and trimethoprim | 29 0.29 6.40 urinary tract antiseptics | 5 0.05 6.45 miscellaneous antibacterial agents | 48 0.48 6.93 quinolones/derivatives | 75 0.75 7.68 antifungals | 3 0.03 7.71 antiviral agents | 21 0.21 7.92 deficiency anemias | 19 0.19 8.11 anticoagulants/thrombolytics | 58 0.58 8.69 hemostatics/antihemophelics | 2 0.02 8.71 cardiac glycosides | 11 0.11 8.82 antiarrhythmic agents | 6 0.06 8.88 antianginal agents | 58 0.58 9.46 agents used to treat shock/hypotension | 13 0.13 9.59 antihypertensive agents | 36 0.36 9.95 diuretics | 39 0.39 10.34 coronary vasodilators | 5 0.05 10.39 relaxants/stimulants, urinary tract | 2 0.02 10.41 calcium channel blockers | 40 0.40 10.81 beta blockers | 31 0.31 11.12 alpha agonist/alpha blockers | 33 0.33 11.45 ace inhibitors | 22 0.22 11.67 sedatives and hypnotics | 382 3.82 15.49 antianxiety agents | 119 1.19 16.68 antipsychotic/antimanics | 34 0.34 17.02 antidepressants | 42 0.42 17.44 anorexiants/cns stimulants | 2 0.02 17.46 cns, miscellaneous | 2 0.02 17.48 alzheimer-type dementia | 2 0.02 17.50 antiemetics | 6 0.06 17.56 diagnostics, radiopaque & nonradioactiv | 4 0.04 17.60 disorders, acid/peptic | 154 1.54 19.14 antidiarrheals | 14 0.14 19.28 laxatives | 33 0.33 19.61 miscellaneous gastrointestinals | 21 0.21 19.82 antispasmodics/anticholinergics | 17 0.17 19.99 antacids | 36 0.36 20.35 hyperlipidemia | 26 0.26 20.61 vitamins/minerals | 22 0.22 20.83 nutrition, enteral/parenteral | 12 0.12 20.95 repl/regs of electrolytes/water balance | 108 1.08 22.03 calcium metabolism | 4 0.04 22.07 adrenal corticosteroids | 120 1.20 23.27 androgens/anabolic steroids | 1 0.01 23.28 estrogens/progestins | 8 0.08 23.36 blood glucose regulators | 38 0.38 23.74 thyroid/antithyroid | 22 0.22 23.96 contraceptives | 4 0.04 24.00 immunologic agents, unspecified | 1 0.01 24.01 vaccines/antisera | 59 0.59 24.60 antiseptics/disinfectants | 17 0.17 24.77 dermatologics, misc. | 11 0.11 24.88 topical steroids | 39 0.39 25.27 burn/sunburn, sunscreen/suntan products | 1 0.01 25.28 topical anti-infectives | 28 0.28 25.56 dermatitis/antipruritics | 1 0.01 25.57 topical analgesics | 8 0.08 25.65 extrapyramidal movement disorders | 5 0.05 25.70 skeletal muscle hyperactivity | 119 1.19 26.89 anticonvulsants | 46 0.46 27.35 hormonal/biological response mod. | 1 0.01 27.36 dna damaging drugs | 1 0.01 27.37 ophthalmic drugs, unspecified | 1 0.01 27.38 cycloplegics/mydriatics | 1 0.01 27.39 ocular anti-infective/anti-inflammatory | 17 0.17 27.56 miscellaneous ophthalmics | 6 0.06 27.62 otic, topical (misc) | 21 0.21 27.83 vertigo/motion sickness/vomiting | 48 0.48 28.31 analgesics/general | 15 0.15 28.46 analgesics, narcotic | 641 6.41 34.87 analgesics, non-narcotic | 383 3.83 38.70 antimigraine/other headaches | 3 0.03 38.73 antiarthritics | 26 0.26 38.99 antigout | 8 0.08 39.07 nsaid | 542 5.42 44.49 antiprotozoals | 17 0.17 44.66 scabicides/pediculicides | 3 0.03 44.69 respiratory tract drugs, unspecified | 2 0.02 44.71 antiasthmatics/bronchodilators | 198 1.98 46.69 nasal decongestants | 40 0.40 47.09 antitussives/expectorants/mucolytics | 63 0.63 47.72 antihistamines | 120 1.20 48.92 cold remedies | 3 0.03 48.95 corticosteroid-inhalation/nasal | 18 0.18 49.13 miscellaneous/unclassified | 1 0.01 49.14 unclassified | 69 0.69 49.83 pharmaceutical aids | 2 0.02 49.85 homeopathic products | 3 0.03 49.88 . | 5,012 50.12 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016